Ethnic variation in the impact of metabolic syndrome components and chronic kidney disease

被引:4
作者
Sabanayagam, Charumathi [1 ,2 ,3 ]
Teo, Boon Wee [4 ]
Tai, E. Shyong [4 ]
Jafar, Tazeen H. [5 ]
Wong, Tien Y. [1 ,3 ]
机构
[1] Singapore Eye Res Inst, Singapore 168751, Singapore
[2] Duke NUS Grad Med Sch, Off Clin Sci, Singapore, Singapore
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore
[4] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore
[5] Duke NUS Grad Med Sch, Program Hlth Serv & Syst Res, Singapore, Singapore
基金
英国医学研究理事会;
关键词
Asians; Blood pressure; CKD; Ethnicity; Metabolic syndrome; BODY-MASS INDEX; STAGE RENAL-DISEASE; WAIST CIRCUMFERENCE; DIABETES-MELLITUS; RISK-FACTORS; EYE DISEASES; PREVALENCE; POPULATION; ASSOCIATION; CKD;
D O I
10.1016/j.maturitas.2013.01.006
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To examine the ethnic differences in the association between metabolic syndrome components and CKD in Asian populations. Methods: We analyzed data from three independent populations in Singapore representing the three major Asian ethnic groups (n = 3167 Chinese, 3082 Malays and 3228 Indians) aged 40-80 years. CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2). Factor analysis of metabolic syndrome components was conducted and factor scores were used as independent variables in multivariable logistic regression models. Results: The prevalence of CKD was highest among Malays (21.0% vs. 7.4%, 5.9% in Indians and Chinese). Factor analysis identified three factors among Chinese (glycemia, blood pressure [BP], and obesity/lipid) and Malays (glycemia, BP, and lipids) accounting for 70% of the variance and four factors (glycemia, BP, lipids, and obesity) among Indians accounting for 82% of the variance, Glycemia was positively associated with CKD in all three ethnic groups. BP was positively associated with CKD among Malays (OR [95% CI] of 1.16 [1.06-1.28]), whereas it showed an inverse association among Chinese (0.84 [0.71-0.99]) and Indians (0.84 [0.73-0.97]). However, this inverse association lost significance after adjusting for antihypertensive medication use in Chinese and Indians. Obesity/lipids among Chinese and obesity among Indians showed a positive association; lipids showed an inverse association among Malays. Conclusions: These data suggest that while hyperglycemia was associated with CKD in all three ethnic groups, the impact of BP, lipids, obesity on CKD varies across ethnic groups. Understanding the specific associations may allow greater understanding of how CKD develops in different racial/ethnic groups. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:369 / 374
页数:6
相关论文
共 56 条
[1]   Metabolic Syndrome Derived from Principal Component Analysis and Incident Cardiovascular Events: The Multi Ethnic Study of Atherosclerosis (MESA) and Health, Aging, and Body Composition (Health ABC) [J].
Agarwal, Subhashish ;
Jacobs, David R., Jr. ;
Vaidya, Dhananjay ;
Sibley, Christopher T. ;
Jorgensen, Neal W. ;
Rotter, Jerome I. ;
Chen, Yii-Der Ida ;
Liu, Yongmei ;
Andrews, Jeanette S. ;
Kritchevsky, Stephen ;
Goodpaster, Bret ;
Kanaya, Alka ;
Newman, Anne B. ;
Simonsick, Eleanor M. ;
Herrington, David M. .
CARDIOLOGY RESEARCH AND PRACTICE, 2012, 2012
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]  
American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4
[5]  
[Anonymous], 2005, FORW EX SUMM, P5
[6]  
[Anonymous], 2011, NAT HLTH SURV 2010
[7]   Association between the metabolic syndrome and chronic kidney disease in Chinese adults [J].
Chen, Jing ;
Gu, Dongfeng ;
Chen, Chung-Shiuan ;
Wu, Xigui ;
Hamm, L. Lee ;
Muntner, Paul ;
Batuman, Vecihi ;
Lee, Chien-Hung ;
Whelton, Paul K. ;
He, Jiang .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (04) :1100-1106
[8]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[9]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[10]  
Enas Enas A, 2007, J Cardiometab Syndr, V2, P267, DOI 10.1111/j.1559-4564.2007.07392.x